Year in Review
2022 NCBIO Year in Review
2022 NCBIO Year in Review From the NCBIO President | Laura Gunter I look back on the past twelve months of NCBIO’s work, and what stands out most to me is how much time and effort we have put into looking forward. The year was perhaps most notable for the completion of our new strategic…
Read More2022 NCBIO Year in Review
In this past year, we emerged from the isolation of COVID-19 thanks in no small part to the heroic work of the life sciences industry in developing vaccines, rapid tests and new treatments that have made the pandemic much more manageable. In spite of this success, we have faced tremendous pressure at the federal level with threats to intellectual property, the lifeblood of the industry, and a push to insert price controls with potential repercussions on innovation.
Read MoreNCBIO 2020-2021 Year in Review
NCBIO looks back on a year defined by the COVID-19 pandemic and the death of our longtime president and co-founder, Sam Taylor. The organization continued to advocate for state and federal public policies that encourage the growth of life science companies and supports the development of a strong life science workforce.
Read More